SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Jun-24 4:48 PM View: | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 50% 23.11K to 34.58K | |
14-Jun-24 4:18 PM View: | Intellia Therapeutics, Inc. (NTLA) | 12-Jun-24 | Grant | 7,737 | -- | -- | 64% 12.0K to 19.73K | |
10-Jun-24 4:15 PM View: | Cytokinetics Inc. (CYTK) | 10-Jun-24 | Private Sale | 2,000 | $52.07 | $104,140.00 | (10%) 19.63K to 17.63K | |
11-Jun-24 4:22 PM View: | Veracyte, Inc. (VCYT) | 10-Jun-24 | Sale (Planned) | 3,870 | $20.32 | $78,633.80 | (14%) 26.98K to 23.11K | |
30-May-24 4:41 PM View: | Veracyte, Inc. (VCYT) | 28-May-24 | Sale (Planned) | 1,539 | $21.00 | $32,319.00 | (5%) 28.51K to 26.98K | |
16-May-24 6:17 PM View: | Cytokinetics Inc. (CYTK) | 15-May-24 | Grant | 5,600 | -- | -- | 40% 14.03K to 19.63K | |
02-Nov-23 4:42 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Oct-23 | Sale (Planned) | 265 | $23.90 | $6,333.50 | (2%) 12.26K to 12.0K | |
02-Aug-23 5:19 PM View: | Intellia Therapeutics, Inc. (NTLA) | 31-Jul-23 | Sale (Planned) | 265 | $42.33 | $11,217.50 | (2%) 12.53K to 12.26K | |
07-Jul-23 4:17 PM View: | Cytokinetics Inc. (CYTK) | 07-Jul-23 | Market Sale | 2,000 | $34.12 | $68,234.60 | (12%) 16.03K to 14.03K | (5%) |
10-Jul-23 5:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 06-Jul-23 | Sale (Planned) | 1,867 | $39.30 | $73,373.10 | (13%) 14.39K to 12.53K | |
21-Jun-23 4:55 PM View: | Veracyte, Inc. (VCYT) | 16-Jun-23 | Sale (Planned) | 5,893 | $26.44 | $155,786.00 | (17%) 34.41K to 28.51K | |
13-Jun-23 5:21 PM View: | Veracyte, Inc. (VCYT) | 09-Jun-23 | Grant | 9,674 | -- | -- | 39% 24.73K to 34.41K | |
01-Jun-23 5:06 PM View: | Veracyte, Inc. (VCYT) | 30-May-23 | Sale (Planned) | 1,539 | $25.91 | $39,875.50 | (6%) 26.27K to 24.73K | |
18-May-23 4:33 PM View: | Cytokinetics Inc. (CYTK) | 10-May-23 | Grant | 5,000 | -- | -- | 45% 11.03K to 16.03K | |
05-Oct-22 4:18 PM View: | Cytokinetics Inc. (CYTK) | 03-Oct-22 | Grant | 220 | $51.11 | $11,244.20 | 2% 10.81K to 11.03K | |
12-Jul-22 4:08 PM View: | Cytokinetics Inc. (CYTK) | 01-Jul-22 | Grant | 274 | $41.00 | $11,234.00 | 3% 10.54K to 10.81K | |
16-Jun-22 8:12 PM View: | Veracyte, Inc. (VCYT) | 16-Jun-22 | Grant | 14,731 | -- | -- | 128% 11.54K to 26.27K | |
17-Jun-22 4:21 PM View: | Ardelyx, Inc. (ARDX) | 15-Jun-22 | Grant | 95,802 | -- | -- | 100% 0 to 95.8K | |
16-Jun-22 6:19 PM View: | Intellia Therapeutics, Inc. (NTLA) | 14-Jun-22 | Grant | 2,014 | -- | -- | 25% 7.95K to 9.97K | |
11-May-22 6:04 PM View: | Cytokinetics Inc. (CYTK) | 10-May-22 | Grant | 5,000 | -- | -- | 90% 5.54K to 10.54K | |
02-May-22 9:49 PM View: | Intellia Therapeutics, Inc. (NTLA) | 28-Apr-22 | Grant | 7,954 | -- | -- | 100% 0 to 7.95K | |
01-Apr-22 7:16 PM View: | Cytokinetics Inc. (CYTK) | 01-Apr-22 | Grant | 293 | $38.38 | $11,245.30 | 6% 5.24K to 5.54K | (7%) |
04-Jan-22 4:46 PM View: | Cytokinetics Inc. (CYTK) | 03-Jan-22 | Grant | 244 | $46.00 | $11,224.00 | 5% 5.0K to 5.24K | 0% |
13-May-21 8:01 PM View: | Cytokinetics Inc. (CYTK) | 12-May-21 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
23-Mar-21 4:48 PM View: | Veracyte, Inc. (VCYT) | 19-Mar-21 | Grant | 11,541 | -- | -- | 100% 0 to 11.54K |